Salehi Omid, Vega Eduardo A, Mellado Sebastian, Core Michael J, Li Mu, Kozyreva Olga, Kutlu Onur C, Freeman Richard, Conrad Claudius
Department of Surgery, St. Elizabeth's Medical Center, Boston University School of Medicine, 11 Nevins St., Suite 201, Brighton, Boston, MA, 02135, USA.
Tufts University School of Medicine, Boston, MA, USA.
J Gastrointest Surg. 2022 Jun;26(6):1241-1251. doi: 10.1007/s11605-022-05290-4. Epub 2022 Apr 8.
Oncologic surgery for T1b-T3 gallbladder carcinoma (GBC) consists of gallbladder fossa resection or bisegmentectomy IVb/V with negative margins and portal/retropancreatic lymphadenectomy. Frequency of high quality oncologic surgery, factors associated with its use, and the ability of chemotherapy to rescue low-quality surgery (LQS) remain unknown.
The NCDB was queried for patients diagnosed with stage I-III (T1b-T3) GBC undergoing curative-intent surgery from 2004 to 2016. These patients were divided into two groups based on receiving high quality surgery (HQS) or not; HQS was defined as cholecystectomy with partial hepatectomy, lymph node harvest ≥ 6, and negative margins. Logistic regression and Kaplan-Meier survival analyses were performed.
A total of 3796 patients met inclusion criteria; only 364 (9.6%) met HQS criteria, and 3432 (90.4%) did not achieve HQS and were deemed low-quality surgery (LQS). HQS was associated with improved median overall survival (55.1 vs. 25.5 months, P < .001). Adjuvant chemotherapy (AC) was not able to rescue LQS with poorer survival compared to HQS without AC (27.9 vs 55.1 months, P < .001). Factors associated with HQS included private insurance (OR 1.809, P < .001), higher income (OR 1.380, P = .038), urban/rural residence (vs metropolitan) (OR 1.641, P = .001), higher education (OR 1.342, P = .031), Medicaid expansion states (OR 1.405, P = .005), stage 3 GBC (OR 1.642, P = .020), and reresection (OR 2.685, P < .001). Factors associated with LQS included older age (OR 0.974, P < .001), comorbidities (OR 0.701, P = .004), and laparoscopic approach (0.579, P < .001). Facility type incrementally improved HQS rate (integrated cancer network vs. comprehensive community, 9.8% vs. 6.1%, OR 1.694, P = .003; academic/research center vs. integrated cancer network, 14.9% vs. 9.8%, OR 1.599, P = .003).
While HQS for GBC strongly improves survival, it is infrequently practiced. The newly identified factors that improve survival for GBC, such as centralization, open approach, and insurance coverage, are modifiable and, therefore, should be considered to achieve optimal outcomes.
T1b - T3期胆囊癌(GBC)的肿瘤外科手术包括胆囊窝切除术或IVb/V段肝段切除术,切缘阴性,并进行肝门/胰后淋巴结清扫术。高质量肿瘤外科手术的频率、与其使用相关的因素以及化疗挽救低质量手术(LQS)的能力尚不清楚。
查询国家癌症数据库(NCDB)中2004年至2016年接受根治性手术的I - III期(T1b - T3)GBC患者。这些患者根据是否接受高质量手术(HQS)分为两组;HQS定义为胆囊切除术联合部分肝切除术、淋巴结清扫≥6枚且切缘阴性。进行逻辑回归和Kaplan - Meier生存分析。
共有3796例患者符合纳入标准;仅364例(9.6%)符合HQS标准,3432例(90.4%)未达到HQS标准,被视为低质量手术(LQS)。HQS与中位总生存期改善相关(55.1个月对25.5个月,P <.001)。辅助化疗(AC)无法挽救LQS患者,其生存期比未接受AC的HQS患者更差(27.9个月对55.1个月,P <.001)。与HQS相关的因素包括私人保险(OR 1.809,P <.001)、高收入(OR 1.380,P =.038)、城乡居住地(与大城市相比)(OR 1.641,P =.001)、高学历(OR 1.342,P =.031)、医疗补助扩大州(OR 1.405,P =.005)、3期GBC(OR 1.642,P =.020)和再次手术(OR 2.685,P <.001)。与LQS相关的因素包括年龄较大(OR 0.974,P <.001)、合并症(OR 0.701,P =.004)和腹腔镜手术方式(0.579,P <.001)。医疗机构类型逐步提高了HQS率(综合癌症网络与综合社区相比,9.8%对6.1%,OR 1.694,P =.003;学术/研究中心与综合癌症网络相比,14.9%对9.8%,OR 1.599,P =.003)。
虽然GBC的HQS能显著提高生存率,但实际应用并不常见。新发现的改善GBC生存率的因素,如集中化、开放手术方式和保险覆盖,是可以改变的,因此,应考虑这些因素以实现最佳治疗效果。